Mepro Pharmaceuticals Private Limited — Clotrimazole Exporter Profile
Indian Pharmaceutical Exporter · #8 for Clotrimazole · $2.2M export value · DGFT Verified
Mepro Pharmaceuticals Private Limited is the #8 Indian exporter of Clotrimazole with $2.2M in export value and 121 verified shipments. Mepro Pharmaceuticals Private Limited holds a 2.4% market share in Clotrimazole exports across 16 countries. The company exports 11 pharmaceutical products worth $17.5M across 6 therapeutic categories.
Mepro Pharmaceuticals Private Limited — Clotrimazole Export Profile: Buyers & Destinations
Where Does Mepro Pharmaceuticals Private Limited Export Clotrimazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CONGO | $456.1K | 11 | 21.2% |
| AUSTRALIA | $372.0K | 15 | 17.3% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $299.8K | 15 | 13.9% |
| CHILE | $296.9K | 17 | 13.8% |
| ANGOLA | $228.3K | 15 | 10.6% |
| CONGO D REPULIC | $222.6K | 6 | 10.3% |
| UNITED ARAB EMIRATES | $75.1K | 12 | 3.5% |
| NETHERLANDS | $57.6K | 11 | 2.7% |
| CONGO THE DEMOCRATIC REPUBLIC OF THE | $55.6K | 4 | 2.6% |
| JORDAN | $21.7K | 1 | 1.0% |
Mepro Pharmaceuticals Private Limited exports Clotrimazole to 17 countries. The largest destination is CONGO accounting for 21.2% of Mepro Pharmaceuticals Private Limited's Clotrimazole shipments, followed by AUSTRALIA (17.3%) and CONGO, THE DEMOCRATIC REPUBLIC OF THE (13.9%). These destinations reflect Mepro Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clotrimazole from Mepro Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M S SANTEVIE SARL | CONGO | $325.4K | 9 |
| M/S.SANTEVIE SARL, | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $310.9K | 14 |
| M/S.SANTEVIE SARL | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $211.6K | 7 |
| M SSANTEVIE SARL | CONGO | $179.6K | 5 |
| ASCEND LABORATORIES SPA | CHILE | $146.0K | 11 |
| NOVA PHARMACEUTICALS AUSTRALASIA BELLA VISTA NSW | AUSTRALIA | $132.2K | 4 |
| NOVA PHARMACEUTICALS AUSTRALASIA | AUSTRALIA | $112.6K | 3 |
| ASCEND LABORATORIES SPA; | CHILE | $112.4K | 5 |
| SOCAGROP | ANGOLA | $90.9K | 7 |
| NOVA PHARMACEUTICALS AUSTRALASIA PT | AUSTRALIA | $80.0K | 5 |
Mepro Pharmaceuticals Private Limited supplies Clotrimazole to 31 buyers globally. The largest buyer is M S SANTEVIE SARL (CONGO), followed by M/S.SANTEVIE SARL, (CONGO, THE DEMOCRATIC REPUBLIC OF THE) and M/S.SANTEVIE SARL (CONGO, THE DEMOCRATIC REPUBLIC OF THE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clotrimazole Export Value and How Much Does Mepro Pharmaceuticals Private Limited Contribute?
India exported $58.5M worth of Clotrimazole through 10,037 shipments from 712 suppliers to 158 countries, serving 1,728 buyers globally. Mepro Pharmaceuticals Private Limited contributes $2.2M to this total, accounting for 2.4% of India's Clotrimazole exports. Mepro Pharmaceuticals Private Limited ships Clotrimazole to 17 countries through 31 buyers.
What Is the Average Shipment Value for Mepro Pharmaceuticals Private Limited's Clotrimazole Exports?
Mepro Pharmaceuticals Private Limited's average Clotrimazole shipment value is $18.5K per consignment, based on 121 shipments totaling $2.2M. The largest destination is CONGO (21.2% of Mepro Pharmaceuticals Private Limited's Clotrimazole exports).
How Does Mepro Pharmaceuticals Private Limited Compare to Other Indian Clotrimazole Exporters?
Mepro Pharmaceuticals Private Limited ranks #8 among 712 Indian Clotrimazole exporters with a 2.4% market share. The top 3 exporters are CAPLIN POINT LABORATORIES LIMITED ($12.0M), ENCUBE ETHICALS PRIVATE LIMITED ($10.0M), S KANT HEALTHCARE LIMITED ($7.2M). Mepro Pharmaceuticals Private Limited processed 121 shipments to 16 destination countries.
What Clotrimazole Formulations Does Mepro Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS: CANDISTEN DUSTING POWDER Clotrimazole Zinc Oixide and Dimethicone Dusting Powder 50gm. QTY: | $134.8K | 3 |
| PHARMACEUTICAL PRODUCTS CANDISTEN DUSTING POWDER CLOTRIMAZOLE ZINC OIXIDE ANDDIMETHICONE DUSTING POWDER 50GM QTY 16 | $100.0K | 2 |
| PHARMACEUTICAL PRODUCTS: CLOTRIMAZOLE CR | $100.0K | 8 |
| PHARMACEUTICAL PRODUCTS:CLOTRIZONE CREAM. 30GM CLOTRIMAZOLE AND HYDROCORTISONECREAM | $77.2K | 2 |
| PHARMACEUTICAL PRODUCTS: CANDISTEN DUSTING POWDER (CLOTRIMAZOLE , ZINC OIXIDE AND DIMETHICONE DUSTING POWDER 50GM.) QTY: | $64.0K | 4 |
| PHARMACEUTICAL PRODUCTS: CANDISTEN DUSTING POWDER (CLOTRIMAZOLE , ZINC OIXIDE AND DIMETHICONE DUSTING POWDER 50GM) QTY:1 | $63.9K | 4 |
| PHARMACEUTICAL PRODUCTS: CANDISTEN DUSTING POWDER (CLOTRIMAZOLE ZINC OIXIDE ANDDIMETHICONE DUSTING POWDER 50GM) QTY:18NOS | $61.3K | 3 |
| PHARMACEUTICAL PRODUCTS: CANDISTEN DUSTING POWDER (CLOTRIMAZOLE , ZINC OIXIDE AND DIMETHICONE DUSTING POWDER 50GM.) QTY:NOS | $60.0K | 3 |
| PHARMACEUTICAL PRODUCTS: CANDISTEN DUSTING POWDER DIMETHICONE (CLOTRIMAZOLE , ZINC OIXIDE AND DUSTING POWDER 50GM.) (QTY | $57.2K | 3 |
| PHARMACEUTICAL PRODUCTS:CLOZOLE EXTRA ANTI-FUNGAL & ANTI-INFLAMMATORY CREAM CLOTRIMAZOLE AND HYDROCORTISONE CREAM | $55.0K | 2 |
Mepro Pharmaceuticals Private Limited exports 82 distinct Clotrimazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS: CANDISTEN DUSTING POWDER Clotrimazo with 3 shipments worth $134.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Clotrimazole to Key Markets
What Mepro Pharmaceuticals Private Limited must comply with to export Clotrimazole to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Mepro Pharmaceuticals Private Limited Compare to Nearest Clotrimazole Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | GLENMARK PHARMACEUTICALS LIMITED | $4.5M | 428 | 26 | $10.5K |
| 3 | LINCOLN PHARMACEUTICALS LTD | $4.3M | 85 | 17 | $50.0K |
| 8 | MEPRO PHARMACEUTICALS PRIVATE LIMITED ★ | $2.2M | 121 | 16 | $18.5K |
| 9 | KUSUM HEALTHCARE PRIVATE LIMITED | $2.0M | 142 | 13 | $14.0K |
| 10 | CIPLA LIMITED | $1.7M | 147 | 5 | $11.8K |
Mepro Pharmaceuticals Private Limited ranks #8 among 712 Indian Clotrimazole exporters. Average shipment value of $18.5K compared to the market average of $82.1K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and LINCOLN PHARMACEUTICALS LTD.
Which Indian Ports Ship Clotrimazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,379 | 13.7% |
| SAHAR AIR | 1,261 | 12.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,130 | 11.3% |
| JNPT/ NHAVA SHEVA SEA | 939 | 9.4% |
| JNPT | 636 | 6.3% |
| DELHI AIR CARGO ACC (INDEL4) | 517 | 5.2% |
| DELHI AIR | 380 | 3.8% |
| Bombay Air | 358 | 3.6% |
What Other Antifungals Products Does Mepro Pharmaceuticals Private Limited Export?
Mepro Pharmaceuticals Private Limited also exports these antifungals products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Mepro Pharmaceuticals Private Limited's Clotrimazole Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Mepro Pharmaceuticals. The Israel-Iran conflict has disrupted Middle East trade routes, complicating logistics and increasing shipping costs. Additionally, Houthi attacks in the Red Sea have led major shipping lines, including Maersk and MSC, to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effective February 1, 2025. These surcharges have significantly elevated the cost of trading with Europe and the US East Coast, compelling Indian exporters to absorb these costs or renegotiate terms with buyers. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (India–EU FTA), concluded on January 27, 2026, offers a favorable development. This comprehensive agreement aims to liberalize trade and investment between India and the EU, potentially reducing tariffs and enhancing market access for Indian pharmaceutical products. For Mepro Pharmaceuticals, this could translate into increased export opportunities and a more competitive stance in the European market. (en.wikipedia.org)
In the United States, evolving import policies, including the imposition of additional tariffs under Section 232 of the US Trade Expansion Act, have impacted Indian exports. These tariffs affect products such as steel, aluminum, and auto components, totaling approximately $7.5 billion. While the direct impact on pharmaceutical exports is less pronounced, the overall trade environment necessitates strategic navigation to mitigate potential repercussions. (ipfonline.com)
Mepro Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical factor for Indian pharmaceutical exporters. The 2013 FDA bans on certain Indian pharmaceutical companies due to GMP non-compliance underscored the importance of stringent quality control measures. For Mepro Pharmaceuticals, maintaining adherence to FDA, WHO, and EU GMP standards is essential to ensure uninterrupted market access and to uphold the company's reputation in the global pharmaceutical industry. (comcec.org)
About Mepro Pharmaceuticals Private Limited
Mepro Pharmaceuticals Private Limited exports 11 products worth $17.5M. Beyond Clotrimazole, top products include Albendazole, Hydrocortisone, Simvastatin, Zinc, Miconazole. View the complete Mepro Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clotrimazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clotrimazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Mepro Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 121 individual customs records matching Mepro Pharmaceuticals Private Limited exporting Clotrimazole, covering 82 formulations to 17 countries via 31 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 158+ countries, 1,728+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clotrimazole Export Data from Mepro Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Mepro Pharmaceuticals Private Limited's Clotrimazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Mepro Pharmaceuticals Private Limited
Full Company Profile →
11 products · $17.5M total trade · 6 categories
Clotrimazole Stats
Company Overview
Top Products by Mepro Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Mepro Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clotrimazole. For current shipment-level data, contact TransData Nexus.